Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study

Observational studies report a reduction of COPD exacerbations in patients treated with β-blockers. In contrast, the Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (BLOCK COPD) randomised controlled trial which excluded COPD patients with cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Leila, Lahousse, Lies, De Nocker, Phebe, Stricker, Bruno H., Brusselle, Guy G., Verhamme, Katia M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236616/
https://www.ncbi.nlm.nih.gov/pubmed/34195251
http://dx.doi.org/10.1183/23120541.00624-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236616/
https://www.ncbi.nlm.nih.gov/pubmed/34195251
http://dx.doi.org/10.1183/23120541.00624-2020

Ejemplares similares